Company Overview and News
Have you been paying attention to shares of Vishay (VPG - Free Report) ? Shares have been on the move with the stock up 13.4% over the past month. VPG hit a new 52-week high of $44.9 in the previous session. Vishay has gained 76.9% since the start of the year compared to the 10.1% move for the Zacks Computer and Technology sector and the 3.2% return for the Zacks Electronics - Miscellaneous Components industry.
CSWI VPG.WI FN VPG
2018-08-21 247wallst - 2
Stocks were indicated to open marginally higher on Tuesday, which would make a four-day Dow Jones industrials rally, if the gains hold. Earnings season is now about 90% of the way to its end, and more than 70% of the companies exceeded expectations. Still, investors have noted that the stock market volatility in 2018 has been less rewarding for those who have continued to buy on every dip than had been the case for several years.
HON SYMC DAVA ADP AJRD HON FN ADUS ADPVV AAPL ITW TRI EMR MS PAYX
Good day, ladies and gentlemen. Welcome to Fabrinet's Financial Results Conference Call for the Fourth Quarter of Fiscal Year 2018. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instruction on how to participate will be given at that time. As a reminder, today's call is being recorded.
Fabrinet (FN - Free Report) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.86 per share a year ago. These figures are adjusted for non-recurring items.
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
Investors interested in stocks from the Electronics - Miscellaneous Components sector have probably already heard of Fabrinet (FN - Free Report) and Littelfuse (LFUS - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Investors interested in stocks from the Electronics - Miscellaneous Components sector have probably already heard of Fabrinet (FN - Free Report) and Littelfuse (LFUS - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
2018-06-14 seekingalpha - 1
2018-05-30 247wallst - 1
The futures looked solidly higher Wednesday morning as some of the nervousness over the political and banking situation in Italy appeared to have died down. While concern remains, an imminent crisis seems unlikely now.
DB NBL IAC XOM TGT FN AAPL AVGO TRI ABBV HPQ BRCM ABBV
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to FN / Fabrinet on message board site Silicon Investor.
as of ET